140 related articles for article (PubMed ID: 32523021)
1. Long-term outcome of posterior fossa medulloblastoma in patients surviving more than 20 years following primary treatment in childhood.
Frič R; Due-Tønnessen BJ; Lundar T; Egge A; Kronen Krossnes B; Due-Tønnessen P; Stensvold E; Brandal P
Sci Rep; 2020 Jun; 10(1):9371. PubMed ID: 32523021
[TBL] [Abstract][Full Text] [Related]
2. Posterior fossa medulloblastoma in children and young adults (0-19 years): survival and performance.
Helseth E; Due-Tonnessen B; Wesenberg F; Lote K; Lundar T
Childs Nerv Syst; 1999 Sep; 15(9):451-5; discussion 456. PubMed ID: 10502004
[TBL] [Abstract][Full Text] [Related]
3. [Current and future strategies in interdisciplinary treatment of medulloblastomas, supratentorial PNET (primitive neuroectodermal tumors) and intracranial germ cell tumors in childhood].
Kortmann RD; Kühl J; Timmermann B; Calaminus G; Dieckmann K; Wurm R; Sörensen N; Urban C; Göbel U; Bamberg M
Strahlenther Onkol; 2001 Sep; 177(9):447-61. PubMed ID: 11591018
[TBL] [Abstract][Full Text] [Related]
4. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
[TBL] [Abstract][Full Text] [Related]
5. Long-term neuromotor speech deficits in survivors of childhood posterior fossa tumors: effects of tumor type, radiation, age at diagnosis, and survival years.
Huber JF; Bradley K; Spiegler B; Dennis M
J Child Neurol; 2007 Jul; 22(7):848-54. PubMed ID: 17715277
[TBL] [Abstract][Full Text] [Related]
6. Medulloblastoma in adults: a review of 47 patients treated between 1952 and 1981.
Bloom HJ; Bessell EM
Int J Radiat Oncol Biol Phys; 1990 Apr; 18(4):763-72. PubMed ID: 2323967
[TBL] [Abstract][Full Text] [Related]
7. Early response and long-term results in the radiotherapy of childhood medulloblastoma.
Chin HW; Maruyama Y
J Neurooncol; 1983; 1(1):53-9. PubMed ID: 6678307
[TBL] [Abstract][Full Text] [Related]
8. Medulloblastoma: time-dose relationship based on a 30-year review.
del Charco JO; Bolek TW; McCollough WM; Maria BL; Kedar A; Braylan RC; Mickle JP; Buatti JM; Mendenhall NP; Marcus RB
Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):147-54. PubMed ID: 9747832
[TBL] [Abstract][Full Text] [Related]
9. Protracted radiotherapy treatment duration in medulloblastoma.
Paulino AC; Wen BC; Mayr NA; Tannous R; Loew TW; Goldman FD; Meeks SL; Ryken TC; Buatti JM
Am J Clin Oncol; 2003 Feb; 26(1):55-9. PubMed ID: 12576926
[TBL] [Abstract][Full Text] [Related]
10. Long-term toxic effects of proton radiotherapy for paediatric medulloblastoma: a phase 2 single-arm study.
Yock TI; Yeap BY; Ebb DH; Weyman E; Eaton BR; Sherry NA; Jones RM; MacDonald SM; Pulsifer MB; Lavally B; Abrams AN; Huang MS; Marcus KJ; Tarbell NJ
Lancet Oncol; 2016 Mar; 17(3):287-298. PubMed ID: 26830377
[TBL] [Abstract][Full Text] [Related]
11. Long-term neurologic health and psychosocial function of adult survivors of childhood medulloblastoma/PNET: a report from the Childhood Cancer Survivor Study.
King AA; Seidel K; Di C; Leisenring WM; Perkins SM; Krull KR; Sklar CA; Green DM; Armstrong GT; Zeltzer LK; Wells E; Stovall M; Ullrich NJ; Oeffinger KC; Robison LL; Packer RJ
Neuro Oncol; 2017 May; 19(5):689-698. PubMed ID: 28039368
[TBL] [Abstract][Full Text] [Related]
12. The treatment and prognosis of medulloblastoma in children. A study of 82 verified cases.
Bloom HJ; Wallace EN; Henk JM
Am J Roentgenol Radium Ther Nucl Med; 1969 Jan; 105(1):43-62. PubMed ID: 5774280
[No Abstract] [Full Text] [Related]
13. Medulloblastoma: clinical and biologic aspects.
Packer RJ; Cogen P; Vezina G; Rorke LB
Neuro Oncol; 1999 Jul; 1(3):232-50. PubMed ID: 11550316
[TBL] [Abstract][Full Text] [Related]
14. Medulloblastoma in adults: treatment results and prognostic factors.
Abacioglu U; Uzel O; Sengoz M; Turkan S; Ober A
Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):855-60. PubMed ID: 12377339
[TBL] [Abstract][Full Text] [Related]
15. Quality control of radiotherapeutic treatment of medulloblastoma in a multicentric study: the contribution of radiotherapy technique to tumour relapse. The French Medulloblastoma Group.
Carrie C; Alapetite C; Mere P; Aimard L; Pons A; Kolodie H; Seng S; Lagrange JL; Pontvert D; Pignon T
Radiother Oncol; 1992 Jun; 24(2):77-81. PubMed ID: 1323134
[TBL] [Abstract][Full Text] [Related]
16. From childhood to adulthood: long-term outcome of medulloblastoma patients. The Institut Curie experience (1980-2000).
Frange P; Alapetite C; Gaboriaud G; Bours D; Zucker JM; Zerah M; Brisse H; Chevignard M; Mosseri V; Bouffet E; Doz F
J Neurooncol; 2009 Nov; 95(2):271-279. PubMed ID: 19521664
[TBL] [Abstract][Full Text] [Related]
17. The results of the treatment of childhood medulloblastoma with radiotherapy at Kaunas University of Medicine Hospital in 1994-2000.
Rutkauskiene G; Labanauskas L; Jarusevicius L
Medicina (Kaunas); 2006; 42(1):22-32. PubMed ID: 16467610
[TBL] [Abstract][Full Text] [Related]
18. Population-based study of medulloblastoma: outcomes in Alberta from 1975 to 1996.
Roldán G; Brasher P; Vecil G; Senger D; Rewcastle B; Cairncross G; Forsyth P; Hamilton M
Can J Neurol Sci; 2008 May; 35(2):210-5. PubMed ID: 18574936
[TBL] [Abstract][Full Text] [Related]
19. Patterns of Failure in Patients With Adult Medulloblastoma Presenting Without Extraneural Metastasis.
Mokhtech M; Morris CG; Indelicato DJ; Rutenberg MS; Amdur RJ
Am J Clin Oncol; 2018 Oct; 41(10):1015-1018. PubMed ID: 29045264
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of salvage re-irradiation in recurrent medulloblastoma correlate with age at initial diagnosis, primary risk-stratification, and molecular subgrouping.
Gupta T; Maitre M; Sastri GJ; Krishnatry R; Shirsat N; Epari S; Sahay A; Chinnaswamy G; Patil V; Shetty P; Moiyadi A
J Neurooncol; 2019 Sep; 144(2):283-291. PubMed ID: 31236820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
